Login / Signup
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.
Xiaoying Chen
Haopeng Zhi
Xiaohu Wang
Zicong Zhou
Huiting Luo
Jing Li
Roma Sehmi
Paul M O'Byrne
Ruchong Chen
Published in:
Lung (2024)
These results indicate the clinical benefit of omalizumab, dupilumab, and mepolizumab in patients with ABPA. Further randomized, controlled studies with a larger sample size and longer follow-up are needed to confirm these findings.
Keyphrases
</>
atopic dermatitis
double blind
open label
placebo controlled
phase ii
clinical trial
allergic rhinitis